In QuotedData’s morning briefing 22 November 2024: Schroder British Opportunities (SBO) has announced a non-material change to its investment policy, whereby it will remove the following paragraph that makes reference to the United Nations’ Sustainable Development Goals: “The Company will focus on companies which the Portfolio Managers consider to be sustainable from an environmental, social […]
Miton UK MicroCap (MINI) has issued a statement saying that, following its engagement with shareholders on the future direction of the company – which MINI’s board said it would do given the level of redemption requests received for the 2024 Redemption Point – the board has concluded that it is the best interest of shareholders […]
Worldwide Healthcare (WWH) has issued an announcement following up on the results of its AGM on 10 July 2024, where the resolutions to re-elect Doug McCutcheon and Sven Borho as directors of the company had more than 20% of votes cast against the respective resolutions (all other votes passed comfortably). The board acknowledges that some […]
In QuotedData’s morning briefing 18 November 2024: Following its recently announced partial compulsorily redemption (which is expected to take place on 29 November 2024), CATCo Reinsurance Opportunities (CAT) will have redeemed the entirety of its interest in the Master Fund and distributed substantially all of the redemption proceeds it has received. Consequently, CAT’s board is […]
CORXEL Pharmaceuticals, a portfolio company of RTW Biotech Opportunities (RTW), has had a new drug application accepted by China’s National Medical Products Administration (NMPA). The application acceptance is for the use of Aficamten for the treatment of obstructive hypertrophic cardiomyopathy (HCM). RTW describes Aficamten as “an investigational, next-in-class selective small molecule cardiac myosin inhibitor”. The […]
Following its announcement on 14 October that it intended to offer shareholders annual tender offers (click here to see our coverage), AVI Japan Opportunity (AJOT) has now published details of the proposed tender along with a circular in relation to this. Shareholders have the opportunity to tender some, none or all of their shares at […]
Gore Street Energy Storage (GSF) has increased the size of two of its financing facilities – one at project level for its Big Rock project, and one at the company level. GSF’s wholly owned subsidiary, Big Rock ESS Assets LLC, which owns the 200MW / 400MWh Big Rock project in California, has successfully completed a […]
In QuotedData’s morning briefing 15 November 2024: Fondul Proprietatea (FP.) has published its quarterly report for the three months ended 30 September 2024. The Adjusted NAV per share as at 30 September 2024 was RON 0.7319 per share, which is 10.76% higher than its value of RON 0.6608 as at the 31 December 2023. The fund’s […]
Gresham House Energy Storage (GRID) has issued a trading update which says that its manager is confident that operational portfolio revenues will rise in 2024 compared with 2023. There has been an improving trend since the low in the first quarter of 2024, both as portfolio capacity grows and as revenue per MW rates recover. […]
In QuotedData’s morning briefing 11 November 2024: Syncona’s (SYNC’s) portfolio company Autolus Therapeutics (Autolus) has announced that the US Food and Drug Administration (FDA) has granted marketing approval for AUCATZYL® (obe-cel) for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL). Autolus says that the approval was based […]
